Zydus Cadila and Eli Lilly announce research collaborationPharmaceutical Business ReviewZydus would receive potential milestone payments of up to $300 million and royalties on sales upon the successful launch of any compounds derived from the research program. William Chin, vice president of discovery research and clinical investigation ...